Evidence map›Paper›PMID 30488644›Full record

ArticleAging cell2019

Disrupted-in-schizophrenia-1 protects synaptic plasticity in a transgenic mouse model of Alzheimer's disease as a mitophagy receptor.

Zhao-Tao Wang, Mei-Hong Lu, Yan Zhang, Wen-Li Ji, Lei Lei, Wang Wang, Li-Pao Fang, Lu-Wen Wang, Fan Yu, Ji Wang and 9 more

Open access · goldAbstract read
In one paragraph

Article in Aging cell, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 90 citations in OpenAlex.

  1. Beyond Histamine Blockade: Clemastine Fumarate as a Promoter of Myelin Regeneration, Inflammatory Regulation, and Neuroimmune Modulation in CNS Disorders.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Mitochondrial dysfunction in Alzheimer's disease: Guiding the path to targeted therapies.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Review
  16. Article
  17. Functional Relationships between L1CAM, LC3, ATG12, and Aβ.International journal of molecular sciences · 2024
    Article
  18. Article
  19. Article
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 9 institutions in 3 countries.

Zhao-Tao WangDepartment of Neurosurgery, Affiliated Bayi Brain Hospital, General Army Hospital, Southern Medical University, Beijing, China.
Mei-Hong LuJiangsu Key Laboratory of Neuropsychiatric Diseases, Institute of Neuroscience, Soochow University, Suzhou, China.
Yan ZhangDepartment of Neurosurgery, Affiliated Bayi Brain Hospital, General Army Hospital, Southern Medical University, Beijing, China.
Wen-Li JiJiangsu Key Laboratory of Neuropsychiatric Diseases, Institute of Neuroscience, Soochow University, Suzhou, China.
Lei LeiDepartment of Physiology, Liaoning Provincial Key Laboratory of Cerebral Diseases, Dalian Medical University, Dalian, China.
Wang WangJiangsu Key Laboratory of Neuropsychiatric Diseases, Institute of Neuroscience, Soochow University, Suzhou, China.
Li-Pao FangJiangsu Key Laboratory of Neuropsychiatric Diseases, Institute of Neuroscience, Soochow University, Suzhou, China.
Lu-Wen WangDepartment of Pathology, Case Western Reserve University, Cleveland, Ohio.
Fan YuJiangsu Key Laboratory of Neuropsychiatric Diseases, Institute of Neuroscience, Soochow University, Suzhou, China.
Ji WangDepartment of Neurosurgery, Affiliated Bayi Brain Hospital, General Army Hospital, Southern Medical University, Beijing, China.
Zhen-Yu LiDepartment of Neurosurgery, Affiliated Bayi Brain Hospital, General Army Hospital, Southern Medical University, Beijing, China.
Jian-Rong WangHematology Center of Cyrus Tang Medical Institute, Collaborative Innovation Center of Hematology, Key Laboratory of Stem Cells and Biomedical, Materials of Jiangsu Province and Chinese Ministry of Science and Technology, State Key Laboratory of Radiation Medicine and Radioprotection, Soochow University School of Medicine, Suzhou, China.
Ting-Hua WangInstitute of Neuroscience, Kunming Medical University, Kunming, China.
Fei DouCollege of Life Sciences, Beijing Normal University, Beijing, China.
Qin-Wen WangNingbo Key Laboratory of Behavioral Neuroscience, Zhejiang Provincial Key Laboratory of Pathophysiology, School of Medicine, Ningbo University, Ningbo, China.
Xing-Long WangDepartment of Pathology, Case Western Reserve University, Cleveland, Ohio.
Shao LiDepartment of Physiology, Liaoning Provincial Key Laboratory of Cerebral Diseases, Dalian Medical University, Dalian, China.
Quan-Hong MaJiangsu Key Laboratory of Neuropsychiatric Diseases, Institute of Neuroscience, Soochow University, Suzhou, China.
Ru-Xiang XuDepartment of Neurosurgery, Affiliated Bayi Brain Hospital, General Army Hospital, Southern Medical University, Beijing, China.
Soochow University · CNBayi Children's Hospital · CNCase Western Reserve University · USDalian Medical University · CNMinistry of Education · BDSouthern Medical University · CNBeijing Normal University · CNKunming Medical University · CNNingbo University · CN

Funding

Jiangsu Key Laboratory of Translational Research and Therapy for Neuro-Psycho-Diseases BM2013003Jiangsu Provincial Special Program of Medical Science BL2014042Military Medical Science Research Project 16CXZ001National Natural Science Foundation of China 16CXZ001National Natural Science Foundation of China 81870897National Natural Science Foundation of China BK20150347National Natural Science Foundation of China BL2014042National Natural Science Foundation of China BM2013003National Natural Science Foundation of China ZDXKB2016022National Program on Key Basic Research Project 2013CB945602Suzhou Clinical Research Center of Neurological Disease Szzx201503
6 · The paper itself

Abstract

Mitochondrial dysfunction is an early feature of Alzheimer's disease (AD). Accumulated damaged mitochondria, which are associated with impaired mitophagy, contribute to neurodegeneration in AD. We show levels of Disrupted-in-schizophrenia-1 (DISC1), which is genetically associated with psychiatric disorders and AD, decrease in the brains of AD patients and transgenic model mice and in Aβ-treated cultured cells. Disrupted-in-schizophrenia-1 contains a canonical LC3-interacting region (LIR) motif (

Indexed as

MitophagyNeuronal PlasticityAlzheimer DiseaseAmino Acid MotifsAmino Acid SequenceAmyloid beta-Protein PrecursorAnimalsAutophagosomesBrainCarbonyl Cyanide m-Chlorophenyl HydrazoneCognition DisordersDisease Models, AnimalDown-RegulationHeLa CellsHumansMaleAmyloid beta-Protein PrecursorCarbonyl Cyanide m-Chlorophenyl HydrazoneDISC1 protein, humanDisc1 protein, mouseMAP1LC3A protein, humanMicrotubule-Associated ProteinsNerve Tissue ProteinsAlzheimer’s diseaseautophagyDisrupted-in-schizophrenia-1mitochondriamitophagy

Identifiers

PMID30488644
PMCPMC6351828
OpenAlexW2903015819

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.